Clinical trial
Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
NCT00213291 · The Hospital for Sick Children, Other · Completed
Key facts
| NCT number | NCT00213291 |
|---|---|
| Title | Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure |
| Official title | Extended Dosing of Darbepoetin Alfa (Aranesp) for the Management of Anemia in Children With Chronic Renal Failure |
| Lead sponsor | The Hospital for Sick Children, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic |
| Intervention type | Drug |
| Interventions | darbepoetin alfa |
| Enrollment | 40 |
| Start date | Apr 1, 2005 |
| Primary completion | Sep 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 26, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: